The research article provides an update on changes to the Canadian Preventive Care Checklist (PCC) Form© including updates on vitamin D and calcium supplementation, depression screening and lifestyle modifications in obese patients, blood pressure targets in hypertension, dyslipidemia screening, and new vaccination recommendations from the National Advisory Committee on Immunization (NACI). 5 Pages.

This billingual article describes the findings of a cross-sectional, self-administered survey of Canadian family physicians and other health professionals investigating perceived barriers and enablers of advance care planning (ACP) in the primary care setting. 9 pages. Last reviewed March 2019.

The authors aimed to identify opportunities for physicians to engage in ACP discussions and to characterize physician's responses to these opportunities. 7 pages. Last reviewed March 2019.

The authors conducted a systematic review to identify relevant contextual elements, program features, implementation principles, and impacted outcomes to inform policy and practice. 49 pages. Last reviewed March 2019.

This study underscores the need to consider gender identify and sexual orientation at end-of-life. In particular, recognition of intersectionality and social locations is crucial to facilitating positive aging experiences and end-of-life care. 10 pages. Last reviewed March 2019.

The authors explored how discussions about life-sustaining treatment occur and examined the factors which influence physician’s communication strategies with the aim of providing novel insights into how communication can be improved. 15 pages. Last reviewed March 2019.

The authors conducted a systematic review to determine the effect of structured communication tools for end-of-life decision making in contrast to usual care. 19 pages. Last reviewed March 2019.

The authors conducted a narrative review of evidence regarding advance care planning and end-of-life communication. 10 pages. Last reviewed March 2019.

This publication summarizes the literature on the evidence of using endocannabinoid system medications and their ability to modulate neuroinflammation and oxidative stress in Alzheimer’s Disease. 15 pages. Last reviewed March 2019.

Pages